Deficiency of MLKL prevents necroptosis in multiple cell types, including tumor cells, macrophages, and fibroblasts (Sun et al., 2012; Zhao et al., 2012; Wu et al., 2013; Wang et al., 2014). Here, MLKL is linked to neoplasm.